4//SEC Filing
Hamdy Ahmed MD 4
Accession 0000950170-23-041517
CIK 0001796129other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 6:28 PM ET
Size
7.3 KB
Accession
0000950170-23-041517
Insider Transaction Report
Form 4
Hamdy Ahmed MD
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2023-08-10$0.96/sh+5,400$5,167→ 96,060 total(indirect: By Trust) - Purchase
Common Stock
2023-08-09$0.95/sh+16,900$15,994→ 90,660 total(indirect: By Trust)
Holdings
- 1,618,199
Common Stock
Footnotes (2)
- [F1]Represents a weighted average purchase price. Actual purchase prices ranged from $0.88 to $0.95 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
- [F2]Represents actual price.
Documents
Issuer
Vincerx Pharma, Inc.
CIK 0001796129
Entity typeother
Related Parties
1- filerCIK 0001458506
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 6:28 PM ET
- Size
- 7.3 KB